Dermbiont
Boston, United States · Founded 2017 · $71.2M raised
- Headquarters
- Boston, Massachusetts
- Founded
- 2017
- Business Model
- B2B
- Website
- dermbiont.com
- Total Funding
- $71.2M
- Last Round
- $35.2M Series BOct 2023
- Rounds
- 3
About
Precision dermatology biotech developing and commercializing targeted topical therapeutics for skin diseases.
Summary
Dermbiont is a Biotech company based in Boston, United States, founded in 2017. It has raised $71.2M in total across 3 rounds, most recently a $35.2M Series B round in Oct 2023. Investors include Viking Global, Olive Tree Capital and Toba Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company